Yazar "Reisli, I." seçeneğine göre listele
Listeleniyor 1 - 10 / 10
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Autosomal-Recessive Agammaglobulinemia Due to Homozygous Mutations in Artemis: Do We Need a Modifier?(Springer/Plenum Publishers, 2014) Volk, T.; Reisli, I.; Bjorkman, A.; Pannicke, U.; Fisch, P.; Schaeffer, A. A.; Bulashevska, A.[Abstract Not Availabe]Öğe Clinical, Laboratory Features and Outcomes of Patients with DOCK 8 Deficiency: Report of 6 Cases(Springer/Plenum Publishers, 2014) Haskologlu, S.; Dogu, F.; Keles, S.; Aytekin, C.; Reisli, I.; Ikinciogullari, A.; Chatila, T.[Abstract Not Availabe]Öğe Hematopoetic Stem Cell Transplantation (HSCT) for Primary Immunodeficiency Diseases (PIDS): Clinical Features and Outcome (A Single Center Experience)(Springer/Plenum Publishers, 2014) Akelma, A. Z.; Dogu, F.; Haskologlu, S.; Cipe, F.; Aytekin, C.; Reisli, I.; Yuksek, M.[Abstract Not Availabe]Öğe IDENTIFICATION OF A NOVEL MUTATION IN THE COMPLEMENT FACTOR 3 GENE IN A PATIENT WITH RECURRENT PNEUMOCOCCAL PNEUMONIA(Springer/Plenum Publishers, 2012) Santos-Valente, E.; Reisli, I.; Artac, H.; Ott, R.; Sanal, O.; Boztug, K.[Abstract Not Availabe]Öğe A Patient with Combined Immunodeficiency and Hemolytic Anemia(Springer/Plenum Publishers, 2014) Sayar, E. Hazar; Guner, S. N.; Emiroglu, M.; De Saint-Basile, G.; Reisli, I.[Abstract Not Availabe]Öğe RETROSPECTIVE EVALUATION OF PATIENTS WHO WERE FOLLOWED WITH THE DIAGNOSIS OF PRIMARY IMMUNODEFICIENCY BETWEEN 2006-2011 IN KONYA(Springer/Plenum Publishers, 2012) Kinali, Y.; Reisli, I.; Gokturk, B.; Kirac, M.; Keles, S.[Abstract Not Availabe]Öğe Severe Combined Immune Deficiency Due To Heterozygous Compound Mutation in Rag1 Gene(Springer/Plenum Publishers, 2014) Artac, H.; Ozdemir, H.; Ceylan, A.; Uygun, V.; Yesilipek, A.; Guner, S.; Reisli, I.[Abstract Not Availabe]Öğe THROMBOCYTE VOLUME AND COUNT IN DIGEORGE SYNDROME(Springer/Plenum Publishers, 2012) Gokturk, B.; Reisli, I.; Kirac, M.; Keles, S.; Artac, H.; Yildirim, S.[Abstract Not Availabe]Öğe Type III bare lymphocyte syndrome associated with a novel RFXAP mutation: a case report(Wiley-Blackwell, 2012) Gokturk, B.; Artac, H.; van Eggermond, M. J.; van den Elsen, P.; Reisli, I.Type III bare lymphocyte syndrome (BLS) is a severe combined immunodeficiency disease caused by the absence of MHC Class II expression associated with low expression of class I molecules. Here, we report a case with type III BLS who lacked RFXAP (Regulatory factor X-associated protein) expression as a result from a novel mutation introducing a premature stopcodon in DE-region at amino acid 73.Öğe UNUSUAL NON-HODGKIN LYMPHOMA SUBTYPES IN CHILDREN WITH PRIMARY IMMUNODEFICIENCY(Wiley-Blackwell, 2013) Uner, A.; Caliskan, U.; Ugras, N. S.; Reisli, I.; Artac, H.; Kose, D.; Koksal, Y.[Abstract Not Availabe]
